Mechanism of action of narcolepsy medications

CNS spectrums

Volumn 19, Issue , 2014, Pages 25-34

  Gowda, Chandan R ^a   Lundt, Leslie P ^a  

^a Rehabilitation Institute at Santa Barbara   (United States)

Author keywords

Cataplexy; hypersomnia; hypocretin; narcolepsy; orexin; sleep

Indexed keywords

ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; DOPAMINE UPTAKE INHIBITOR; MONOAMINE OXIDASE INHIBITOR; NEUROPEPTIDE; OREXINS; OXYBATE SODIUM; SIGNAL PEPTIDE; TRICYCLIC ANTIDEPRESSANT AGENT; WAKEFULNESS PROMOTING AGENT;

CATAPLEXY; HUMAN; METABOLISM; NARCOLEPSY;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CATAPLEXY; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE UPTAKE INHIBITORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MONOAMINE OXIDASE INHIBITORS; NARCOLEPSY; NEUROPEPTIDES; SODIUM OXYBATE; WAKEFULNESS-PROMOTING AGENTS;

EID: 84925232320     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852914000583     Document Type: Review

References (0)